UBS AM’s Acceleron Pharma Inc. XLRN Stock Holding History

UBS AM’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-237,506	Closed	-$40.9M	–	2943
2021 Q3	$40.9M	Buy	237,506 +9,617	+4%	+$1.66M	0.02%	684
2021 Q2	$28.6M	Buy	227,889 +37,135	+19%	+$4.66M	0.01%	793
2021 Q1	$25.9M	Sell	190,754 -47,995	-20%	-$6.51M	0.01%	794
2020 Q4	$30.5M	Buy	238,749 +5,426	+2%	+$694K	0.01%	736
2020 Q3	$26.3M	Sell	233,323 -28,301	-11%	-$3.18M	0.01%	695
2020 Q2	$24.9M	Buy	261,624 +4,069	+2%	+$388K	0.02%	680
2020 Q1	$23.1M	Sell	257,555 -89,297	-26%	-$8.03M	0.02%	634
2019 Q4	$18.4M	Buy	346,852 +31,889	+10%	+$1.69M	0.01%	797
2019 Q3	$12.4M	Sell	314,963 -35,986	-10%	-$1.42M	0.01%	887
2019 Q2	$14.4M	Buy	350,949 +5,445	+2%	+$224K	0.01%	845
2019 Q1	$16.1M	Sell	345,504 -4,955	-1%	-$231K	0.01%	797
2018 Q4	$15.3M	Buy	350,459 +67,176	+24%	+$2.93M	0.01%	764
2018 Q3	$16.2M	Sell	283,283 -44,797	-14%	-$2.56M	0.01%	815
2018 Q2	$15.9M	Sell	328,080 -84,230	-20%	-$4.09M	0.01%	825
2018 Q1	$16.1M	Sell	412,310 -23,053	-5%	-$901K	0.01%	807
2017 Q4	$18.5M	Buy	435,363 +109,913	+34%	+$4.66M	0.02%	768
2017 Q3	$12.1M	Buy	325,450 +4,718	+1%	+$176K	0.01%	859
2017 Q2	$9.75M	Buy	+320,732	New	+$9.75M	0.01%	908
2016 Q4	–	Sell	-10,600	Closed	-$384K	–	2736
2016 Q3	$384K	Hold	10,600	–	–	﹤0.01%	2133
2016 Q2	$360K	Hold	10,600	–	–	﹤0.01%	2136
2016 Q1	$280K	Sell	10,600 -162,624	-94%	-$4.3M	﹤0.01%	2252
2015 Q4	$8.45M	Buy	173,224 +52,327	+43%	+$2.55M	0.01%	902
2015 Q3	$3.01M	Buy	120,897 +5,105	+4%	+$127K	﹤0.01%	1252
2015 Q2	$3.66M	Buy	115,792 +5,092	+5%	+$161K	﹤0.01%	1150
2015 Q1	$4.21M	Sell	110,700 -2,700	-2%	-$103K	﹤0.01%	1092
2014 Q4	$4.42M	Sell	113,400 -2,300	-2%	-$89.6K	﹤0.01%	1065
2014 Q3	$3.5M	Sell	115,700 -5,100	-4%	-$154K	﹤0.01%	1121
2014 Q2	$4.1M	Buy	120,800 +56,200	+87%	+$1.91M	﹤0.01%	1087
2014 Q1	$2.23M	Sell	64,600 -500	-0.8%	-$17.3K	﹤0.01%	1276
2013 Q4	$2.58M	Buy	+65,100	New	+$2.58M	﹤0.01%	1176